The Link Between Health Literacy & Cancer Communication Eastman, Peggy Eastman, Peggy Less Oncology Times. 41(16):1,5-6, August 20, 2019. Favorite PDF Permissions Free
Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia Less Oncology Times. 41(16):1,7, August 20, 2019. Favorite PDF Permissions Free
Immunotherapy for Patients With Melanoma Metastatic to the Brain Holt, Chuck Holt, Chuck Less Oncology Times. 41(16):1,4,6, August 20, 2019. Favorite PDF Permissions Free
ASCO Guidelines Direct Clinical Decisions for Biliary Tract Cancer Holt, Chuck Holt, Chuck Less Oncology Times. 41(16):8-9, August 20, 2019. Favorite PDF Permissions Free CME Test
Mogamulizumab-Kpkc (Poteligeo®) Shultes, Kendall C. Shultes, Kendall C. Less Oncology Times. 41(16):16, August 20, 2019. Favorite PDF Permissions Free
Breast Tumor Profile Fortifies Risk Gene Panel in Younger Patients Samson, Kurt Samson, Kurt Less Oncology Times. 41(16):17, August 20, 2019. Favorite PDF Permissions Free
BIS Technology: Prevention of Cancer-Related Lymphedema Ridner, Sheila Ridner, Sheila Less Oncology Times. 41(16):18-19, August 20, 2019. Favorite PDF Permissions Free
Wearable Devices Show Potential for Improving Outcomes in Cancer Patients Wolfgang, Kelly Wolfgang, Kelly Less Oncology Times. 41(16):21, August 20, 2019. Favorite PDF Permissions Free
The Role of Informatics in Precision Oncology Less Oncology Times. 41(16):22, August 20, 2019. Favorite PDF Permissions Free
Traditional & Complementary Treatments for Mesothelioma Patients Less Oncology Times. 41(16):24, August 20, 2019. Favorite PDF Permissions Free
When Prostate Cancer Recurs After Primary Radiation Therapy Gallagher, Amy Gallagher, Amy Less Oncology Times. 41(16):25, August 20, 2019. Favorite PDF Permissions Free
Genetic Testing Motivates Behavior Changes in Families at Risk for Melanoma Less Oncology Times. 41(16):26, August 20, 2019. Favorite PDF Permissions Free
Study Finds Novel Mechanism of Action for NK Cells in Checkpoint Inhibitor Less Oncology Times. 41(16):27, August 20, 2019. Favorite PDF Permissions Free
Genetically Unrelated Lesions Can Lead to Ovarian Cancer Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 41(16):28-29, August 20, 2019. Favorite PDF Permissions Free
Extending PARP Inhibitor Treatment to More Cancer Patients Less Oncology Times. 41(16):30, August 20, 2019. Favorite PDF Permissions Free
Pembrolizumab Provides Long-Term Survival in Advanced Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(16):33, August 20, 2019. Favorite PDF Permissions Free
Combination Checkpoint Inhibition “Big Win” for Worst Kidney Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(16):34-35, August 20, 2019. Favorite PDF Permissions Free
Interleukin Superagonist N-803 Helps Avoid Cystectomy in Bladder Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(16):36, August 20, 2019. Favorite PDF Permissions Free
RET-Targeted Therapy Success in Thyroid Cancers Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(16):37, August 20, 2019. Favorite PDF Permissions Free
Pembrolizumab Comparable to Chemo in Advanced Gastric Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(16):38, August 20, 2019. Favorite PDF Permissions Free
3 Questions On... How Pediatric CNS Tumor Diagnoses Affect Patients in Adulthood: With M. Douglas Ris, PhD, of Baylor College of Medicine and Texas Children's Hospital DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 41(16):42, August 20, 2019. Favorite PDF Permissions Free
FDA Updates Highlighting the Latest Cancer Treatments Less Oncology Times. 41(16):11-15, August 20, 2019. Favorite PDF Permissions Free
